bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.04.18.537407

Uncovering protein-protein interactions of the human sodium channel Nav1.7

zhou, l. x.·Zhao, J.
View original source ↗Export metadata ↓

Abstract

The voltage-gated sodium channel Nav1.7 plays a crucial role in the initiation and propagation of pain signals. Our previous study has successfully identified the interacting proteins of mouse Nav1.7 (mNav1.7). In this study, we aimed to further elucidate the protein-protein interactions associated with human Nav1.7 (hNav1.7). Stable epitope (TAP)-tagged HEK293 cells expressing hNaV1.7 were utilized for the identification of hNav1.7-interacting proteins. The hNaV1.7-associated complexes were isolated through tandem affinity purification and further characterized by mass spectrometry. Bioinformatics analysis was carried out using the PANTHER classification system. Electrophysiological recording was performed to assess Nav1.7 current. Tap-tagged hNav1.7 was expressed effectively in HEK293 cells, exhibiting normal functional Nav1.7 currents. A total of 261 proteins were identified as interactors of hNav1.7, mainly located across the cell membrane and cytoplasm, and primarily involved in biological processes related to protein translation and expression. Comparison between human and mouse Nav1.7-interacting proteins revealed shared proteins (such as Eef1a1, Eef2, Tcp1, Cct2, Cct3, Cct5, Cct6a, and Cct7) as well as protein families (such as kinesin and Rab GTPases family). Knockdown of two of the shared interacting proteins, CCT5 and TMED10, resulted in reduced Nav1.7 current density. In conclusion, the protein interactions of hNaV1.7 were successfully mapped in the current work. These novel findings offer essential insights into the regulatory mechanisms that govern Nav1.7 function. Significance statementChronic pain affects approximately 20% of the worlds population and is a global major public health problem. Nav1.7 has been recognized as a promising target for novel analgesics. However, the drug development process for Nav1.7 is challenging. A thorough understanding of the regulatory mechanism of Nav1.7 would greatly assist in the development of its analgesic drugs. Our previous work successfully mapped the mNav1.7 protein interactions. In the current study, the interacting proteins of hNav1.7 were further defined. Our findings provide important implications for the development of Nav1.7-based analgesics for human use.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

zhou, l. x., Zhao, J.. 2023-04-19. Uncovering protein-protein interactions of the human sodium channel Nav1.7. https://doi.org/10.1101/2023.04.18.537407

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗